Imugene Limited is a biotechnology company developing immunotherapies for cancer treatment, focusing on harnessing the body’s immune system to target and eradicate tumors.
Ticker code: IMU
Sector: Healthcare | Industry: Biotechnology | Website: https://www.imugene.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $121,809,968 | $105,558,360 | 300765343.0 | 84.3 | $102,682,198 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $61,656,894 | $21,935,432 | $10,651,476 | None | None | -18.3 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| None | 9.0 | $502,177 | $1,148,548 | None | 0.0 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | None |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $0.405 | -2.4 | 12.5 | 50.0 | 50.0 | -54.2 | -74.7 |
IMU Price Chart with Volume and 3EMA
IMU Short Positions
Click HERE to understand why the above moving averages have been chosen.